Impact of guideline adherence and expert center referral on the early management and outcomes of uterine sarcoma patients: A retrospective analysis from the French NETSARC network

Eur J Surg Oncol. 2024 Feb;50(2):107319. doi: 10.1016/j.ejso.2023.107319. Epub 2023 Dec 23.

Abstract

Objective: Uterine sarcomas are rare tumors with a poor prognosis. Their diagnosis is often incidental, following surgery. Our goal was to examine the early management strategies for uterine sarcomas, and to assess the impact of guideline adherence and expert center referral on both the management approaches and the clinical outcomes in patients with uterine sarcomas.

Methods: We retrospectively analyzed medical records from patients with uterine sarcoma referred to the Institut Curie and registered in the database of the French NETSARC network.

Results: In total, 100 patients, with a median age of 54 years, were included in the analyses. On MRI scans (n = 36), all patients had at least two signs suggestive of malignancy, and 77.8 % had four or more signs. No preoperative biopsy was performed in 65.6 % of cases. Only 14.1 % of patients underwent initial surgery at an expert center. Surgery performed outside the network was significantly associated with morcellation (32.9 % vs. 0 %; p = 0.036), fewer negative margins (R0 margins 52.4 % vs. 100 %; p = 0.006), and poor adherence to surgical guidelines (28.3 vs. 72.7 %; p = 0.013). Multivariate analysis showed that non-adherence to surgical recommendations was not significantly associated with relapse-free survival (HR = 0.54; 95 % CI [0.21-1.38]), but was an independent predictor of poor overall survival (HR = 0.12; 95 % CI [0.03-0.52]; p = 0.005).

Conclusion: Despite a high frequency of suspicious clinical and radiological signs, a large proportion of women undergoing sarcoma surgery are treated outside of expert networks. We provide guidelines, integrating the clinical context and radiological signs to encourage early referral to reference centers for sarcoma.

Keywords: Biopsy; Clinical practice guidelines; Compliance; Surgery; Tumor board; Uterine sarcoma.

MeSH terms

  • Female
  • Guideline Adherence
  • Humans
  • Middle Aged
  • Pelvic Neoplasms*
  • Referral and Consultation
  • Retrospective Studies
  • Sarcoma* / diagnostic imaging
  • Sarcoma* / surgery
  • Soft Tissue Neoplasms* / surgery
  • Uterine Neoplasms* / diagnosis
  • Uterine Neoplasms* / surgery